Justin Trudeau on Tuesday said Canada has secured up to 26,000 doses of bamlanivimab, a therapeutic drug used for coronavirus treatment, manufactured by Eli Lilly.“This treatment was developed in partnership with Vancouver’s AbCellera Biologics and is part of our support for researchers right here at home who are working around the clock to find a treatment for COVID-19,” he said.